Author: De Stefano, Ludovico; Bobbio-Pallavicini, Francesca; Manzo, Antonio; Montecucco, Carlomaurizio; Bugatti, Serena
Title: A “Window of Therapeutic Opportunity†for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019 Cord-id: j76726no Document date: 2020_10_6
ID: j76726no
Snippet: The effects of cytokine inhibition in the different phases of the severe coronavirus disease 2019 (COVID-19) are currently at the center of intense debate, and preliminary results from observational studies and case reports offer conflicting results thus far. The identification of the correct timing of administration of anti-cytokine therapies and other immunosuppressants in COVID-19 should take into account the intricate relationship between the viral burden, the hyperactivation of the innate i
Document: The effects of cytokine inhibition in the different phases of the severe coronavirus disease 2019 (COVID-19) are currently at the center of intense debate, and preliminary results from observational studies and case reports offer conflicting results thus far. The identification of the correct timing of administration of anti-cytokine therapies and other immunosuppressants in COVID-19 should take into account the intricate relationship between the viral burden, the hyperactivation of the innate immune system and the adaptive immune dysfunction. The main challenge for effective administration of anti-cytokine therapy in COVID-19 will be therefore to better define a precise “window of therapeutic opportunity.†Only considering a more specific set of criteria able to integrate information on direct viral damage, the cytokine burden, and the patient’s immune vulnerability, it will be possible to decide, carefully balancing both benefits and risks, the appropriateness of using immunosuppressive drugs even in patients affected primarily by an infectious disease.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and adaptive innate immune response: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and adaptive innate immune response viral damage: 1
- acute ards respiratory distress syndrome and adequate control: 1
- acute ards respiratory distress syndrome and liver damage: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute ards respiratory distress syndrome and low specific: 1, 2, 3
- acute inflammatory mechanism and liver damage: 1
- adaptive innate and adequate control: 1
- adaptive innate and liver damage: 1, 2, 3, 4
- adaptive innate and long history: 1
- adequate control and low specific: 1, 2
- liver damage and low specific: 1
Co phrase search for related documents, hyperlinks ordered by date